Comprehensive quality evaluation of Tangwei capsule based on HPLC-QAMS multi-index quantitative determination combined with chemometrics and EW-TOPSIS method
OBJECTIVES: To detect the contents of Tangwei capsule main components with high performance liquid chromatography-quantitative analysis of multicomponents by single marker (HPLC-QAMS) method and to evaluate the quality with chemometrics and entropy weight-technique for order preference by similarity to an ideal solution (EW-TOPSIS).
METHODS: A symmetry C18 column and 0.1% formic acid-acetonitrile as mobile phase were used for HPLC of Tangwei capsule. The contents of 3'-hydroxypuerarin, puerarin, 3'-methoxypuerarin, methylnissolin-3-O-glucoside, calycosin, formononetin, rosmarinic acid, salvianolic acid B, dihydrotanshinone Ⅰ, cryptotanshinone, tanshinone Ⅰ, tanshinone ⅡA and cucurbitacin B in 15 batches of Tangwei capsule were determined simultaneously. The quality differences of 15 batches of samples were analyzed by chemometrics and EW-TOPSIS.
RESULTS: The HPLC-UV showed that 13 components had good linear relationships in corresponding concentration ranges (r≥0.9991). The relative standard deviations (RSD) of precision, repeatability and stability were all less than 2.00%. The average recovery rates were between 96.86% and 100.13%, and RSD were all less than 2.00%. Cluster analysis showed that 15 batches of samples were clustered into 3 groups. Partial least squares-discriminant analysis showed that salvianolic acid B, formononetin, puerarin, 3'-methoxypuerarin and rosmarinic acid were the main potential markers affecting the quality of Tangwei capsule. EW-TOPSIS analysis showed that the quality of S12-S15 was superior.
CONCLUSIONS: The analytical method established in this study can be used for the comprehensive evaluation of the quality of Tangwei capsule to provide laboratory support for its quality control and overall evaluation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences - 52(2023), 2 vom: 25. Apr., Seite 195-206 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
高效液相一测多评法多指标成分定量联合化学计量学、熵权优劣解距离法用于糖维胶囊综合质量评价 |
---|
Beteiligte Personen: |
Qiu, Hui [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.06.2023 Date Revised 13.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.3724/zdxbyxb-2022-0519 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357849701 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM357849701 | ||
003 | DE-627 | ||
005 | 20231227131313.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3724/zdxbyxb-2022-0519 |2 doi | |
028 | 5 | 2 | |a pubmed24n1225.xml |
035 | |a (DE-627)NLM357849701 | ||
035 | |a (NLM)37283104 | ||
035 | |a (PII)1008-9292(2023)02-0195-12 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Qiu, Hui |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comprehensive quality evaluation of Tangwei capsule based on HPLC-QAMS multi-index quantitative determination combined with chemometrics and EW-TOPSIS method |
246 | 3 | 3 | |a 高效液相一测多评法多指标成分定量联合化学计量学、熵权优劣解距离法用于糖维胶囊综合质量评价 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.06.2023 | ||
500 | |a Date Revised 13.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: To detect the contents of Tangwei capsule main components with high performance liquid chromatography-quantitative analysis of multicomponents by single marker (HPLC-QAMS) method and to evaluate the quality with chemometrics and entropy weight-technique for order preference by similarity to an ideal solution (EW-TOPSIS) | ||
520 | |a METHODS: A symmetry C18 column and 0.1% formic acid-acetonitrile as mobile phase were used for HPLC of Tangwei capsule. The contents of 3'-hydroxypuerarin, puerarin, 3'-methoxypuerarin, methylnissolin-3-O-glucoside, calycosin, formononetin, rosmarinic acid, salvianolic acid B, dihydrotanshinone Ⅰ, cryptotanshinone, tanshinone Ⅰ, tanshinone ⅡA and cucurbitacin B in 15 batches of Tangwei capsule were determined simultaneously. The quality differences of 15 batches of samples were analyzed by chemometrics and EW-TOPSIS | ||
520 | |a RESULTS: The HPLC-UV showed that 13 components had good linear relationships in corresponding concentration ranges (r≥0.9991). The relative standard deviations (RSD) of precision, repeatability and stability were all less than 2.00%. The average recovery rates were between 96.86% and 100.13%, and RSD were all less than 2.00%. Cluster analysis showed that 15 batches of samples were clustered into 3 groups. Partial least squares-discriminant analysis showed that salvianolic acid B, formononetin, puerarin, 3'-methoxypuerarin and rosmarinic acid were the main potential markers affecting the quality of Tangwei capsule. EW-TOPSIS analysis showed that the quality of S12-S15 was superior | ||
520 | |a CONCLUSIONS: The analytical method established in this study can be used for the comprehensive evaluation of the quality of Tangwei capsule to provide laboratory support for its quality control and overall evaluation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chemometrics | |
650 | 4 | |a Entropy weight-technique for order preference by similarity to an ideal solution | |
650 | 4 | |a High performance liquid chromatography-quantitative analysis of multicomponents by single marker | |
650 | 4 | |a Quality evaluation | |
650 | 4 | |a Tangwei capsule | |
650 | 7 | |a salvianolic acid B |2 NLM | |
650 | 7 | |a C1GQ844199 |2 NLM | |
650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
700 | 1 | |a Wen, Feiying |e verfasserin |4 aut | |
700 | 1 | |a Fang, Jian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hongyuan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences |d 2002 |g 52(2023), 2 vom: 25. Apr., Seite 195-206 |w (DE-627)NLM123207037 |x 1008-9292 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2023 |g number:2 |g day:25 |g month:04 |g pages:195-206 |
856 | 4 | 0 | |u http://dx.doi.org/10.3724/zdxbyxb-2022-0519 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2023 |e 2 |b 25 |c 04 |h 195-206 |